GLOBAL WEARABLE ARTIFICIAL KIDNEY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global Wearable Artificial Kidney Market, By Disease Stage (Acute Renal Disease and End-stage Renal Disease), By Dialysis Type (Hemodialysis and Peritoneal dialysis), By End User (Hospitals, Ambulatory Surgical Centers, Dialysis Centers, and Others), and Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
In June 2023, AWAK Technologies, a medical technology company, and Singapore General Hospital (SGH) announced the launch of a pre-pivotal clinical trial with the enrolment of their first subject to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device.
In August 2022, The Kidney Innovation Accelerator (KidneyX), a public-private partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases, announced the funding of US$ 10.5 Mn in funding for the further development of a fully functional bioartificial kidney.